Canopy Growth Corporation (CGC) vs Eikon Therapeutics, Inc. Common Stock (EIKN)

A side-by-side comparison of Canopy Growth Corporation and Eikon Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Canopy Growth Corporation logo
CGC
Canopy Growth Corporation
$375M
$0.89HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$408M
$7.54HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — CGC vs EIKN

growth of $100 · dividends reinvested · last 1y
CGC -23.7% (-23.7%/yr)EIKN -49.7% (-49.7%/yr)CGC compounded faster over this window
6080100Start $100$76$50
CGC EIKN

CGC vs EIKN: by the numbers

  • •EIKN is the larger company ($408M vs $375M market cap).
  • •Both run net losses; EIKN's is the smaller (0.00% vs -81.04% net margin).

Metrics side by side

Valuation

MetricCGCEIKN
P/S ratio1.63N/A
P/B ratio0.770.88

Profitability

MetricCGCEIKN
Gross margin25.47%0.00%
Operating margin-31.98%0.00%
Net margin-81.04%0.00%
ROE-38.57%-69.06%
ROIC-10.85%-46.16%

Growth (annualized)

MetricCGCEIKN
Revenue CAGR (5Y)-12.47%N/A
Total return CAGR (5Y)-63.36%N/A

Go deeper

Full CGC analysisFull EIKN analysisInteractive comparison tool

Dig into the metrics

Canopy Growth ROEEikon Therapeutics, Inc. Common Stock ROECanopy Growth operating marginEikon Therapeutics, Inc. Common Stock operating marginCanopy Growth revenue growthEikon Therapeutics, Inc. Common Stock revenue growthCanopy Growth free cash flowEikon Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.